• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东呼吸综合征冠状病毒(MERS-CoV):科学现状

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.

作者信息

Mostafa Ahmed, Kandeil Ahmed, Shehata Mahmoud, El Shesheny Rabeh, Samy Abdallah M, Kayali Ghazi, Ali Mohamed A

机构信息

Center of Scientific Excellence for Influenza Viruses, Environmental Research Division, National Research Centre (NRC), Cairo 12622, Egypt.

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

出版信息

Microorganisms. 2020 Jul 2;8(7):991. doi: 10.3390/microorganisms8070991.

DOI:10.3390/microorganisms8070991
PMID:32630780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7409282/
Abstract

Coronaviruses belong to a large family of viruses that can cause disease outbreaks ranging from the common cold to acute respiratory syndrome. Since 2003, three zoonotic members of this family evolved to cross species barriers infecting humans and resulting in relatively high case fatality rates (CFR). Compared to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV, CFR = 10%) and pandemic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, CFR = 6%), the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has scored the highest CFR (approximately 35%). In this review, we systematically summarize the current state of scientific knowledge about MERS-CoV, including virology and origin, epidemiology, zoonotic mode of transmission, and potential therapeutic or prophylactic intervention modalities.

摘要

冠状病毒属于一个庞大的病毒家族,可引发从普通感冒到急性呼吸综合征等一系列疾病爆发。自2003年以来,该家族的三种人畜共患病毒成员进化后跨越物种屏障感染人类,并导致相对较高的病死率(CFR)。与严重急性呼吸综合征冠状病毒(SARS-CoV,病死率=10%)和大流行的严重急性呼吸综合征冠状病毒2(SARS-CoV-2,病死率=6%)相比,中东呼吸综合征冠状病毒(MERS-CoV)的病死率最高(约35%)。在本综述中,我们系统地总结了关于MERS-CoV的科学知识现状,包括病毒学和起源、流行病学、人畜共患传播模式以及潜在的治疗或预防干预方式。

相似文献

1
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.中东呼吸综合征冠状病毒(MERS-CoV):科学现状
Microorganisms. 2020 Jul 2;8(7):991. doi: 10.3390/microorganisms8070991.
2
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.阿贝尔森激酶抑制剂是严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒融合的强效抑制剂。
J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1.
4
Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns.中东呼吸综合征冠状病毒:现状及与旅行相关的问题
Front Med. 2016 Jun;10(2):111-9. doi: 10.1007/s11684-016-0446-y. Epub 2016 May 4.
5
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.紫锥菊制剂 Echinaforce®抗冠状病毒(包括普通感冒冠状病毒 229E 和 SARS-CoV-2)的体外病毒杀灭活性。
Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2.
6
Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.人类致死性人畜共患冠状病毒感染——2019冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较系统发育学、流行病学、传播及临床特征
Curr Opin Pulm Med. 2021 May 1;27(3):146-154. doi: 10.1097/MCP.0000000000000774.
7
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.儿童冠状病毒感染包括 COVID-19:儿童流行病学、临床特征、诊断、治疗和预防选择概述。
Pediatr Infect Dis J. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660.
8
Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.冠状病毒:旅行者中的严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒
Curr Opin Infect Dis. 2014 Oct;27(5):411-7. doi: 10.1097/QCO.0000000000000089.
9
SARS and MERS: recent insights into emerging coronaviruses.严重急性呼吸综合征和中东呼吸综合征:对新型冠状病毒的最新见解
Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27.
10
Broad-spectrum coronavirus antiviral drug discovery.广谱冠状病毒抗病毒药物的发现。
Expert Opin Drug Discov. 2019 Apr;14(4):397-412. doi: 10.1080/17460441.2019.1581171. Epub 2019 Mar 8.

引用本文的文献

1
The Mystery of Certain Strains in the Treatment of Gastrointestinal Symptoms of COVID-19: A Review.新冠病毒感染胃肠道症状治疗中某些毒株的奥秘:综述
Microorganisms. 2025 Apr 19;13(4):944. doi: 10.3390/microorganisms13040944.
2
Pakistan's first MERS-CoV case: A wake up call for global health authorities.巴基斯坦首例中东呼吸综合征冠状病毒病例:给全球卫生当局敲响警钟。
New Microbes New Infect. 2024 Oct 19;62:101516. doi: 10.1016/j.nmni.2024.101516. eCollection 2024 Dec.
3
Mucosal immunity in upper and lower respiratory tract to MERS-CoV.

本文引用的文献

1
Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in Bactrian camels.基于新城疫病毒的中东呼吸综合征冠状病毒候选疫苗在双峰驼中引发高水平且持久的中和抗体。
J Integr Agric. 2017 Oct;16(10):2264-2273. doi: 10.1016/S2095-3119(17)61660-5. Epub 2017 Oct 9.
2
Middle East respiratory syndrome.中东呼吸综合征。
Lancet. 2020 Mar 28;395(10229):1063-1077. doi: 10.1016/S0140-6736(19)33221-0. Epub 2020 Mar 4.
3
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
上、下呼吸道对中东呼吸综合征冠状病毒的黏膜免疫
Front Immunol. 2024 Aug 30;15:1358885. doi: 10.3389/fimmu.2024.1358885. eCollection 2024.
4
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir.中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶中针对临床应用抑制剂奈玛特韦和恩西他韦耐药的关键残基研究。
Npj Viruses. 2024;2(1):23. doi: 10.1038/s44298-024-00028-2. Epub 2024 Jun 24.
5
Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1.抗病毒反应与病毒诱导的细胞关闭:甲型流感病毒NS1与严重急性呼吸综合征冠状病毒2 Nsp1之间的权力游戏
Front Cell Infect Microbiol. 2024 Feb 5;14:1357866. doi: 10.3389/fcimb.2024.1357866. eCollection 2024.
6
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID-19, avian influenza, and MERS-CoV.研究实验室在东地中海区域大流行和传染病应对中的作用:COVID-19、禽流感和 MERS-CoV 的经验。
Influenza Other Respir Viruses. 2024 Feb;18(2):e13257. doi: 10.1111/irv.13257.
7
Zoonosis and zooanthroponosis of emerging respiratory viruses.新发呼吸道病毒的人畜共患病和动物源人兽共患病。
Front Cell Infect Microbiol. 2024 Jan 5;13:1232772. doi: 10.3389/fcimb.2023.1232772. eCollection 2023.
8
Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in Humans.人类接种中东呼吸综合征冠状病毒疫苗后鉴定出一个刺突特异性 CD8+ T 细胞表位。
J Infect Dis. 2024 Aug 16;230(2):e327-e332. doi: 10.1093/infdis/jiad612.
9
Isolation and genetic characterization of MERS-CoV from dromedary camels in the United Arab Emirates.从阿联酋单峰骆驼中分离出中东呼吸综合征冠状病毒并进行基因特征分析。
Front Vet Sci. 2023 Aug 31;10:1182165. doi: 10.3389/fvets.2023.1182165. eCollection 2023.
10
Exogenous Players in Mitochondria-Related CNS Disorders: Viral Pathogens and Unbalanced Microbiota in the Gut-Brain Axis.线粒体相关中枢神经系统疾病的外源因素:病毒病原体和肠道-脑轴中失衡的微生物群。
Biomolecules. 2023 Jan 13;13(1):169. doi: 10.3390/biom13010169.
预防性和治疗性瑞德西韦(GS-5734)治疗中东呼吸综合征冠状病毒感染恒河猴模型。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.
4
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.比较瑞德西韦与洛匹那韦利托那韦和干扰素β联合治疗中东呼吸综合征冠状病毒的疗效。
Nat Commun. 2020 Jan 10;11(1):222. doi: 10.1038/s41467-019-13940-6.
5
A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice.一种携带中东呼吸综合征冠状病毒短免疫原性肽的重组甲型H1N1流感病毒作为双价疫苗在BALB/c小鼠中的应用
Pathogens. 2019 Dec 2;8(4):281. doi: 10.3390/pathogens8040281.
6
Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.基于重组复制缺陷型狂犬病病毒的二价疫苗(针对 MERS-CoV 和狂犬病病毒)的研制及其在小鼠体内的体液免疫原性。
PLoS One. 2019 Oct 7;14(10):e0223684. doi: 10.1371/journal.pone.0223684. eCollection 2019.
7
Force of infection of Middle East respiratory syndrome in dromedary camels in Kenya.肯尼亚单峰驼中东呼吸综合征感染力度。
Epidemiol Infect. 2019 Sep 24;147:e275. doi: 10.1017/S0950268819001663.
8
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East.中东呼吸综合征冠状病毒(MERS-CoV)在非洲和中东的单峰驼中。
Viruses. 2019 Aug 5;11(8):717. doi: 10.3390/v11080717.
9
Bacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV.基于细菌外膜囊泡(OMVs)的甲型H1N1流感病毒和中东呼吸综合征冠状病毒双价疫苗
Vaccines (Basel). 2019 May 28;7(2):46. doi: 10.3390/vaccines7020046.
10
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.一种基于腺病毒的高度免疫原性、保护性和安全性疫苗,在转基因人二肽基肽酶 4 小鼠模型中表达中东呼吸综合征冠状病毒 S1-CD40L 融合蛋白。
J Infect Dis. 2019 Oct 8;220(10):1558-1567. doi: 10.1093/infdis/jiz137.